<VariationArchive VariationID="827574" VariationName="NM_001369369.1(FOXN1):c.933_936dup (p.Asp313fs)" VariationType="Duplication" Accession="VCV000827574" Version="7" RecordType="classified" NumberOfSubmissions="3" NumberOfSubmitters="3" DateLastUpdated="2024-02-20" DateCreated="2020-03-16" MostRecentSubmission="2024-02-20">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="815778" VariationID="827574">
      <GeneList>
        <Gene Symbol="FOXN1" FullName="forkhead box N1" GeneID="8456" HGNC_ID="HGNC:12765" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>17q11.2</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="28506348" stop="28538900" display_start="28506348" display_stop="28538900" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="26850958" stop="26865174" display_start="26850958" display_stop="26865174" Strand="+" />
          </Location>
          <OMIM>600838</OMIM>
        </Gene>
      </GeneList>
      <Name>NM_001369369.1(FOXN1):c.933_936dup (p.Asp313fs)</Name>
      <CanonicalSPDI>NC_000017.11:28534334:CACCC:CACCCACCC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>17q11.2</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="17" Accession="NC_000017.11" start="28534334" stop="28534335" display_start="28534334" display_stop="28534335" variantLength="4" positionVCF="28534334" referenceAlleleVCF="G" alternateAlleleVCF="GCACC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="17" Accession="NC_000017.10" start="26861352" stop="26861353" display_start="26861352" display_stop="26861353" variantLength="4" positionVCF="26861352" referenceAlleleVCF="G" alternateAlleleVCF="GCACC" />
      </Location>
      <ProteinChange>D313fs</ProteinChange>
      <HGVSlist>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_61" sequenceAccession="LRG_61">
            <Expression>LRG_61:g.15396_15399dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003593.2" sequenceAccession="NM_003593" sequenceVersion="2" change="c.933_936dupACCC">
            <Expression>NM_003593.2:c.933_936dupACCC</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.10" sequenceAccession="NC_000017" sequenceVersion="10" change="g.26861354_26861357dup" Assembly="GRCh37">
            <Expression>NC_000017.10:g.26861354_26861357dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000017.11" sequenceAccession="NC_000017" sequenceVersion="11" change="g.28534336_28534339dup" Assembly="GRCh38">
            <Expression>NC_000017.11:g.28534336_28534339dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_007260.1" sequenceAccession="NG_007260" sequenceVersion="1" change="g.15396_15399dup">
            <Expression>NG_007260.1:g.15396_15399dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_001369369.1" sequenceAccession="NM_001369369" sequenceVersion="1" change="c.933_936dup" MANESelect="true">
            <Expression>NM_001369369.1:c.933_936dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_001356298.1" sequenceAccession="NP_001356298" sequenceVersion="1" change="p.Asp313fs">
            <Expression>NP_001356298.1:p.Asp313fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_003593.3" sequenceAccession="NM_003593" sequenceVersion="3" change="c.933_936dup">
            <Expression>NM_003593.3:c.933_936dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_003584.2" sequenceAccession="NP_003584" sequenceVersion="2" change="p.Asp313fs">
            <Expression>NP_003584.2:p.Asp313fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_61t1" sequenceAccession="LRG_61t1">
            <Expression>LRG_61t1:c.933_936dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_61p1" sequenceAccession="LRG_61p1" change="p.Asp313fs">
            <Expression>LRG_61p1:p.Asp313fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
      <XRefList>
        <XRef Type="Allelic variant" ID="600838.0004" DB="OMIM" />
        <XRef Type="rs" ID="1597566356" DB="dbSNP" />
      </XRefList>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_001369369.1(FOXN1):c.933_936dup (p.Asp313fs) AND T-lymphocyte deficiency" Accession="RCV001027393" Version="3">
        <ClassifiedConditionList TraitSetID="52872">
          <ClassifiedCondition DB="MedGen" ID="C0152094">T-lymphocyte deficiency</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>no assertion criteria provided</ReviewStatus>
            <Description DateLastEvaluated="2020-11-11" SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
      <RCVAccession Title="NM_001369369.1(FOXN1):c.933_936dup (p.Asp313fs) AND T-cell immunodeficiency, congenital alopecia, and nail dystrophy" Accession="RCV001078466" Version="4">
        <ClassifiedConditionList TraitSetID="2412">
          <ClassifiedCondition DB="MedGen" ID="C1866426">T-cell immunodeficiency, congenital alopecia, and nail dystrophy</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description DateLastEvaluated="2022-10-07" SubmissionCount="2">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification DateLastEvaluated="2022-10-07" NumberOfSubmissions="3" NumberOfSubmitters="3" DateCreated="2020-03-16" MostRecentSubmission="2024-02-20">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <Citation Type="general">
          <ID Source="PubMed">10206641</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">15180707</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31447097</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="PubMed">31566583</ID>
        </Citation>
        <Citation Type="general">
          <ID Source="pmc">6819092</ID>
        </Citation>
        <ConditionList>
          <TraitSet ID="2412" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="4527" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Congenital alopecia and nail dystrophy associated with severe functional T-cell immunodeficiency</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Pignata Guarino syndrome</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">T-cell immunodeficiency, congenital alopecia, and nail dystrophy</ElementValue>
                <XRef ID="MONDO:0011132" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="4358" />
                <XRef ID="4358" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="169095" DB="Orphanet" />
              <XRef ID="C1866426" DB="MedGen" />
              <XRef ID="MONDO:0011132" DB="MONDO" />
              <XRef Type="MIM" ID="601705" DB="OMIM" />
            </Trait>
          </TraitSet>
          <TraitSet ID="52872" Type="Disease" ContributesToAggregateClassification="false">
            <Trait ID="5323" Type="Disease">
              <Name>
                <ElementValue Type="Preferred">T-lymphocyte deficiency</ElementValue>
                <XRef ID="398055000" DB="SNOMED CT" />
              </Name>
              <Name>
                <ElementValue Type="Alternate">Immune defect due to absence of thymus</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Thymic aplasia</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Nezelof syndrome</ElementValue>
                <XRef ID="MONDO:0009451" DB="MONDO" />
              </Name>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="7201" />
                <XRef ID="7201" DB="Office of Rare Diseases" />
              </AttributeSet>
              <XRef ID="83471" DB="Orphanet" />
              <XRef ID="C0152094" DB="MedGen" />
              <XRef ID="MONDO:0009451" DB="MONDO" />
              <XRef Type="MIM" ID="242700" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="2454244" SubmissionDate="2020-04-20" DateLastUpdated="2020-05-04" DateCreated="2020-05-04">
        <ClinVarSubmissionID localKey="FOXN1_933_601705" localKeyIsSubmitted="1" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001244846" DateUpdated="2020-05-04" DateCreated="2020-05-04" Type="SCV" Version="1" SubmitterName="van Oers lab, UT Southwestern Medical Center" OrgID="507388" OrganizationCategory="laboratory" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-04-20">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>Pt. presented with compound het mutations in FOXN1- 933 and 1089. T-B+NK+ with normal hair and nails, developed viral infections</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
          <ObservedIn>
            <Sample>
              <Origin>maternal</Origin>
              <Tissue>thymus</Tissue>
              <Species>mouse</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>in vivo</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
            <Citation>
              <ID Source="pmc">6819092</ID>
            </Citation>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name>p.Asp313fs</Name>
          </OtherNameList>
          <AttributeSet>
            <Attribute Type="HGVS">NM_003593.2:c.933_936dupACCC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="OMIM" ID="601705" Type="MIM" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB6788403</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
      <ClinicalAssertion ID="2329930" SubmissionDate="2020-11-11" DateLastUpdated="2020-11-14" DateCreated="2020-03-16">
        <ClinVarSubmissionID localKey="600838.0004_T-CELL IMMUNODEFICIENCY WITH THYMIC APLASIA (1 patient)" title="FOXN1, 4-BP DUP, 933ACCC_T-CELL IMMUNODEFICIENCY WITH THYMIC APLASIA (1 patient)" />
        <ClinVarAccession Accession="SCV001189940" DateUpdated="2020-11-14" DateCreated="2020-03-16" Type="SCV" Version="2" SubmitterName="OMIM" OrgID="3" OrganizationCategory="resource" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2020-11-11">
          <ReviewStatus>no assertion criteria provided</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species>human</Species>
              <AffectedStatus>not provided</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>literature only</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">In a female infant (patient 1), born of unrelated parents, with T-cell immunodeficiency with thymic aplasia (TIDTA; 242700), Du et al. (2019) identified compound heterozygous mutations in the FOXN1 gene: a 4-bp duplication (c.933_936dupACCC), predicted to result in a frameshift and premature termination (Thr313fsTer169), and a 15-bp deletion (c.1089_1103del; 600838.0005), predicted to result in a trp-to-cys substitution followed by an in-frame deletion of 5 highly conserved amino acids (Trp363_Pro367delinsCys). Both mutations occurred in exon 7 in the DNA-binding domain, although c.1089del occurred at the C-terminal region of the DNA-binding domain. The mutations, which were found by exome sequencing, were each inherited from an unaffected parent. Expression of these 2 homologous mutations in mice using genome editing showed variable effects of the mutations on Foxn1 transcriptional activity. Compound heterozygous mutant mice had pronounced thymic hypoplasia with impaired T-cell development but without alopecia or nail bed dystrophy, similar to the phenotype observed in patient 1. In contrast, mice homozygous for the 4-bp duplication were small and had a nude phenotype with thymic aplasia, hair loss, and diminished nail length. Mice homozygous for the 15-bp deletion had thymic hypoplasia with normal hair and nails, similar to compound heterozygous mice. Mice who were heterozygous for either allele were similar to controls. In vitro studies using transcriptional reporter assays showed that the c.933dup mutation resulted in a truncated protein with almost no transcriptional activity, whereas the c.1089del mutation retained 31% activity, indicating differential effects of the mutations depending on the location. Moreover, the decreased transcriptional activity of the c.933dup mutation was shown to affect hair follicles and keratinocytes, whereas the c.1089del mutation did not. These results showed a functional dichotomy in the requirement of FOXN1 in controlling hair and skin development compared to thymus development. Du et al. (2019) concluded that the C-terminal end of the DNA-binding region uncouples thymic epithelial cell development from keratinocyte development.</Attribute>
              <Citation>
                <ID Source="PubMed">31566583</ID>
              </Citation>
              <XRef DB="OMIM" ID="242700" Type="MIM" />
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXN1" />
          </GeneList>
          <Name>FOXN1, 4-BP DUP, 933ACCC</Name>
          <VariantType>Variation</VariantType>
          <OtherNameList>
            <Name Type="NonHGVS">4-BP DUP, 933ACCC</Name>
          </OtherNameList>
          <XRefList>
            <XRef DB="OMIM" ID="600838.0004" Type="Allelic variant" />
          </XRefList>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">T-CELL IMMUNODEFICIENCY WITH THYMIC APLASIA (1 patient)</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
      </ClinicalAssertion>
      <ClinicalAssertion ID="3105182" SubmissionDate="2024-02-08" DateLastUpdated="2024-02-20" DateCreated="2021-05-10">
        <ClinVarSubmissionID localKey="6468238|MedGen:C1866426" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV001579576" DateUpdated="2024-02-20" DateCreated="2021-05-10" Type="SCV" Version="3" SubmitterName="Invitae" OrgID="500031" OrganizationCategory="laboratory" OrgAbbreviation="Invitae" />
        <RecordStatus>current</RecordStatus>
        <Classification DateLastEvaluated="2022-10-07">
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Citation>
            <ID Source="PubMed">31566583</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">10206641</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">15180707</ID>
          </Citation>
          <Citation>
            <ID Source="PubMed">31447097</ID>
          </Citation>
          <Comment>Algorithms developed to predict the effect of sequence changes on RNA splicing suggest that this variant may disrupt the consensus splice site. For these reasons, this variant has been classified as Pathogenic. ClinVar contains an entry for this variant (Variation ID: 827574). This premature translational stop signal has been observed in individual(s) with autosomal recessive severe combined immunodeficiency (PMID: 31566583). This variant is not present in population databases (gnomAD no frequency). This sequence change creates a premature translational stop signal (p.Asp313Thrfs*169) in the FOXN1 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in FOXN1 are known to be pathogenic (PMID: 10206641, 15180707, 31447097).</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">Invitae Variant Classification Sherloc (09022015)</Attribute>
          <Citation>
            <ID Source="PubMed">28492532</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>unknown</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXN1" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NC_000017.10:g.26861352_26861353insCACC</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <XRef DB="MedGen" ID="C1866426" Type="CUI" />
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB12974844</SubmissionName>
          <SubmissionName>SUB14200314</SubmissionName>
          <SubmissionName>SUB8755776</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="2454244" TraitType="Disease" MappingType="XRef" MappingValue="601705" MappingRef="OMIM">
        <MedGen CUI="C1866426" Name="T-cell immunodeficiency, congenital alopecia, and nail dystrophy" />
      </TraitMapping>
      <TraitMapping ClinicalAssertionID="3105182" TraitType="Disease" MappingType="XRef" MappingValue="C1866426" MappingRef="MedGen">
        <MedGen CUI="C1866426" Name="T-cell immunodeficiency, congenital alopecia, and nail dystrophy" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

